Competitive Technologies Appoints George M. Yahwak General Counsel and Senior Licensing Executive.Business Editors FAIRFIELD, Conn.--(BUSINESS WIRE)--Feb. 8, 2000 Competitive Technologies, Inc. (AMEX AMEX See: American Stock Exchange : CTT CTT Correios (Portuguese Postal Service) CTT Certified Technical Trainer CTT Charity Technology Trust CTT Cholesterol Treatment Trialists' (collaboration) CTT Common Task Training ) announced today the appointment of George M. Yahwak as General Counsel and Senior Licensing Executive. Previous General Counsel Michael R. Novack resigned on January 31, 2000 to pursue another opportunity. Mr. Yahwak comes to CTT with a broad background and experience at the US Patent and Trademark Office in Washington DC, corporate experience with Exxon Chemical, Warner Lambert, as well as operating a private law practice. Mr. Yahwak earned his law degree at American University American University, at Washington, D.C.; United Methodist; founded by Bishop J. F. Hurst, chartered 1893, opened in 1914. It was at first a graduate school; an undergraduate college was opened in 1925. Programs provide for student research at many government institutions. . He has a Master of Science degree in immunology-virology and a Bachelor degree in microbiology-chemistry. &uot;George understands the technology commercialization business. He has provided consulting services to CTT, knows our people and can hit the ground running,&uot; said Frank McPike, President of CTT. &uot;In the 1980's Mr. Yahwak worked for University Patents, Inc., and USET USET United States Equestrian Team , Inc. and prosecuted patents for a number of important CTT technologies, including homocysteine Homocysteine Definition Homocysteine is a naturally occurring amino acid found in blood plasma. High levels of homocysteine in the blood are believed to increase the chance of heart disease, stroke, Alzheimer's disease, and osteoporosis. .&uot; &uot;Being a part of the CTT team which is commercializing so many dynamic technologies now is truly exciting. The marketplace requires that we accomplish these actions as quickly as possible,&uot; said Mr. Yahwak. About Competitive Technologies, Inc. Competitive Technologies is a global leader in identifying, developing and commercializing innovative life sciences, physical sciences and digital technologies. Competitive Technologies' specialized expertise and experience make it a valuable partner for companies and universities of all sizes. CTT has been responsible for closing hundreds of licensing agreements. CTT clients include: SONY, Lucent Technologies, Matsushita Electric Industrial and Ribozyme Ribozyme A ribonucleic acid (RNA) molecule that, like a protein, can catalyze specific biochemical reactions. Examples include self-splicing rRNA and RNase P, both involved in catalyzing RNA processing reactions (that is, the biochemical reactions that convert Pharmaceuticals, Inc. Competitive Technologies, Inc. is based in Fairfield, Connecticut Fairfield is a town located in Fairfield County, Connecticut, United States. It is situated along the Gold Coast of Connecticut. Fairfield is a town of many neighborhoods, two of which -- Southport and Greenfield Hill -- are notably affluent. and has affiliates in Osaka, Japan and London, England. Statements about the Company's future expectations, including development and regulatory plans, and all other statements in this document other than historical facts are &uot;forward-looking statements&uot; within the meaning of applicable Federal Securities Laws and are not guarantees of future performance. These statements involve risks and uncertainties related to market acceptance of and competition for the Company's licensed technologies and other risks and uncertainties inherent in CTT's business, including those set forth in Item 1 of the Company's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended July 31, 1999 and other factors that may be described in CTT's filings with the SEC, and are subject to change at any time. The Company's actual results could differ materially from these forward-looking statements. The Company undertakes no obligation to update publicly any forward-looking statement. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion